XBiotech Announces Enrollment Completion, Positive Findings for Bermekimab in Pancreatic Cancer Study

    NEXT STORY
    Progenics Pharmaceuticals Sets First Quarter 2019 Financial Results and Business Update Call for May 9
    PREV STORY
    Corbus Pharmaceuticals Completes Enrollment of RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results

    RSV Phase 3 Prepare™ Trial Outcome De-risked by Successful Informational AnalysisNanoFlu™ Vaccine Demonstrates Improved ...

    author_avatar
    NASDAQ Market News

    Shire plc : CHMP RECOMMENDS EU MARKETING AUTHORIZATION FOR VEYVONDI(R) FOR ADULTS WITH VON WILLEBRAND DISEASE

    CHMP RECOMMENDS EU MARKETING AUTHORIZATION FOR VEYVONDI® [VONICOG ALFA, RECOMBINANT VON WILLEBRAND FACTOR] FOR ...

    author_avatar
    NASDAQ Market News

    Global Travel Vaccines Market Growth at CAGR of 6.83%, 2016-2020: Challenges, Drivers & Trends – Key Drivers are GlaxoSmithKline, Merck, Pfizer & Sanofi

    Dublin, Dec. 16, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

    author_avatar
    NASDAQ Market News